Investment robo-advisors : Some reflections on China's regulatory experience

Journal article


Xiao, Shanyun and Adekola, Tolulope Anthony. (2021). Investment robo-advisors : Some reflections on China's regulatory experience. Banking and Finance Law Review. 37(1), pp. 127-148.
AuthorsXiao, Shanyun and Adekola, Tolulope Anthony
Abstract

Financial advice and investment management are increasingly being provided by automated products called "robo-advisors". While robo-advisors have been considered as a major breakthrough in the Fintech industry, they present significant challenges for regulators who are rather used to human intermediaries. Some of the challenges include algorithmic defects, qualification restrictions, liability shouldering, false propaganda and black box. These challenges undermine investors' confidence and the development of Fintech in general. With a particular focus on China, this article explores the nature of robo-advisors, their core components, and the regulatory puzzles surrounding them. The capacity regulators should develop to maximize the technology's gains. Analysis in this article shows that the existing regulatory framework on robo-advisors in China is too strict and also fails to comply with the twin pillars of financial advisory regulatory framework - know your client and suitability obligation. The article, therefore, offers certain policy recommendations relating to liability system, accountability mechanism, robotic examination standardization, special insurance cover and enhanced user portrait. The article calls for an improved regulatory regime in China that will keep up with the development of robo-advisors and other technology-driven financial innovations in general.

Year2021
JournalBanking and Finance Law Review
Journal citation37 (1), pp. 127-148
PublisherCarswell
ISSN0832-8722
Web address (URL)https://www.proquest.com/scholarly-journals/investment-robo-advisors-some-reflections-on/docview/2607756470/se-2?accountid=8194
Page range127-148
Publisher's version
License
All rights reserved
File Access Level
Controlled
Output statusPublished
Publication dates
OnlineDec 2021
Publication process dates
Deposited03 Jun 2025
Additional information

Copyright HAB Press Limited Dec 2021.

Permalink -

https://acuresearchbank.acu.edu.au/item/91y15/investment-robo-advisors-some-reflections-on-china-s-regulatory-experience

Restricted files

Publisher's version

  • 1
    total views
  • 0
    total downloads
  • 1
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

Regulating genome-edited products – An international trade law perspective
Adekola, Tolulope Anthony, Ediboglu-Sakowsky, Ezgi, Endrich-Laimböck, Tobias, Graßer, Tabea, Hofmeister, Elisabeth, Wilfert, Juna Icaza and Kim, Daria. (2024). Regulating genome-edited products – An international trade law perspective. Max Planck Institute for Innovation and Competition Research Paper Series. 16(4), pp. Paper 24-13. https://doi.org/10.2139/ssrn.4988104
When mRNA technology meets patent law : Innovation, barriers and public health
Adekola, Tolulope Anthony. (2023). When mRNA technology meets patent law : Innovation, barriers and public health. Journal of Intellectual Property Law and Practice. 18(12), pp. 867-877. https://doi.org/10.1093/jiplp/jpad086
uman rights law, intellectual property and vaccine nationalism : Lessons for the post-COVID-19 world
Adekola, Tolulope Anthony and Majekolagbe, Faith O.. (2023). uman rights law, intellectual property and vaccine nationalism : Lessons for the post-COVID-19 world. Australian Journal of Human Rights. 29(2), pp. 375-393. https://doi.org/10.1080/1323238X.2023.2286941
Regional mechanism under DOHA Paragraph 6 system — The largely untested alternative route for access to patented medicines
Adekola, Tolulope Anthony. (2020). Regional mechanism under DOHA Paragraph 6 system — The largely untested alternative route for access to patented medicines. 15(1), pp. 61-90.
Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent
Adekola, Tolulope Anthony. (2020). Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent. European Intellectual Property Review. 42(11), pp. 695-697.
Has the Doha Paragraph 6 system reached its limits?
Adekola, Tolulope. (2020). Has the Doha Paragraph 6 system reached its limits? Journal of Intellectual Property Law and Practice. 15(7), pp. 525-529. https://doi.org/10.1093/jiplp/jpaa058
Abolition of graphical representation in EU trademark directive : Should countries with similar provisions follow EU’s footsteps?
Adekola, Tolulope Anthony. (2019). Abolition of graphical representation in EU trademark directive : Should countries with similar provisions follow EU’s footsteps? Journal of Intellectual Property Rights. 24, pp. 62-68.
Public health–oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment
Adekola, T. A.. (2019). Public health–oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment. Public Health. 173, pp. 1-4. https://doi.org/10.1016/j.puhe.2019.04.019
US–China trade war and the WTO dispute settlement mechanism
Adekola, Tolulope Anthony. (2019). US–China trade war and the WTO dispute settlement mechanism. Journal of International Trade Law and Policy. 18(3), pp. 125-135. https://doi.org/10.1108/JITLP-02-2019-0011